Skip to main content
Clinical Trials/ISRCTN10324656
ISRCTN10324656
Active, not recruiting
Phase 4

Beta-blockers Or Placebo for Primary Prophylaxis of oesophageal varices (BOPPP): a blinded, multi-centre, clinical effectiveness and cost-effectiveness randomised controlled trial

King’s College Hospital NHS Foundation Trust0 sites763 target enrollmentDecember 4, 2018

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Participants with cirrhosis and small varices without evidence of previous bleeding
Sponsor
King’s College Hospital NHS Foundation Trust
Enrollment
763
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35113923/ results of the embedded qualitative study (added 04/02/2022) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/36251653/ results of the embedded qualitative study (added 18/10/2022) 2024 Protocol article in https://doi.org/10.1186/s13063-024-08063-3 (added 17/04/2024)

Registry
who.int
Start Date
December 4, 2018
End Date
December 31, 2026
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \>18 years
  • 2\. Cirrhosis and portal hypertension, defined by any two of the following:
  • 2\.1\. Characteristic clinical examination findings; one or more of:
  • 2\.1\.1\. Jaundice, ascites, caput medusae, spider naevi, palmar erythema, asterixis
  • 2\.2\. Characteristic liver function tests, haematological panel and coagulation profile abnormalities
  • 2\.2\.1\. hyperbilirubinaemia (serum total bilirubin \> 30 umol/l)
  • 2\.2\.2\. thrombocytopenia (platelet count \<120 x109 / L)
  • 2\.2\.3\.international normalised raio (INR) \> 1\.5
  • NB These blood tests may be normal in well compensated cirrhosis – if cirrhosis is confirmed on other investigations, normal blood tests suggest well compensated disease.
  • 2\.3\. Characteristic radiological findings; one or more of:

Exclusion Criteria

  • 1\. Non\-cirrhotic portal hypertension
  • 2\. Medium/large oesophageal varices (current or history of)
  • 3\. Isolated gastric, duodenal, rectal varices with or without evidence of recent bleeding
  • 4\. Previous variceal haemorrhage
  • 5\. Known intolerance to beta blockers
  • 6\. Contraindication to beta blocker use:
  • 6\.1\. Heart rate \<50 bpm
  • 6\.2\. Known 2nd degree or higher heart block
  • 6\.3\. Sick sinus syndrome
  • 6\.4\. Systolic blood pressure \<85mm Hg

Outcomes

Primary Outcomes

Not specified

Similar Trials